Results 1 to 10 of about 415,727 (126)

Significance of interleukin-31 (IL-31) gene polymorphisms and IL-31 serum level in psoriasis in correlation with pruritus. [PDF]

open access: yesPostepy Dermatol Alergol, 2021
Interleukin-31 (IL-31) impact on the development and clinical presentation of psoriasis as well as pruritus has not been widely investigated so far.To analyse IL-31 -1066G/A and -2057G/A promoter gene polymorphisms as well as serum IL-31 level and their correlation with severity of psoriasis and pruritus in the population of northern Poland.The study ...
Purzycka-Bohdan D   +7 more
europepmc   +4 more sources

Increased levels of interleukin 31 (IL-31) in osteoporosis. [PDF]

open access: yesBMC Immunol, 2015
Several inflammatory cytokines play a key part in the induction of osteoporosis. Until now, involvement of the Th2 cytokine interleukin-31 (IL-31) in osteoporosis hadn't yet been studied. IL-31 is a proinflammatory cytokine mediating multiple immune functions, whose involvement in a wide range of diseases, such as atopic dermatitis, inflammatory bowel ...
Ginaldi L   +6 more
europepmc   +6 more sources

Mechanisims of asthma and allergic disease – 1064. Interleukin 31 (IL 31) serum levels in atopic dermatitis patients [PDF]

open access: yesWorld Allergy Organ J, 2013
Background Atopic dermatitis is a common chronic skin disorder which is a subset of atopy. Atopy refers to a genetic predisposition to respond immunonologically to allergens which are generally harmless, causingover production of immunoglobulin E (IgE) antibodies.
Mohd Ashari N   +5 more
europepmc   +3 more sources

Determination of interleukin 31 (IL-31) serum levels in allergic rhinitis patients

open access: yesInternational Journal of Pediatrics & Adolescent Medicine, 2014
Background and objectives: IL-31 appears to be an important regulator of Th2 re-sponses and was found to be present in patients with atopic dermatitis. This study was con-ducted to compare IL-31 serum levels in allergic rhinitis (AR) patients and normal ...
Noor Suryani Mohd Ashari   +5 more
doaj   +2 more sources

Interleukin-31 as a Clinical Target for Pruritus Treatment

open access: yesFrontiers in Medicine, 2021
In recent years, the published literature has suggested the key involvement of the cytokine interleukin-31 (IL-31) in the symptomatology of pruritus, and both IL-31 and its receptor have become potential therapeutic targets for a range of pruritic ...
Kenji Kabashima, Hiroyuki Irie
doaj   +1 more source

Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis

open access: yesPharmaceutics, 2023
Atopic dermatitis (AD), a pruritic, inflammatory chronic disease with multifactorial pathogenesis, has been a therapeutic challenge. Novel target treatments aim to reduce not only the immunologic dysfunction and microbiome dysbiosis but also the recovery
Raquel Leao Orfali, Valeria Aoki
doaj   +1 more source

The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis

open access: yesFrontiers in Immunology, 2021
Idiopathic Pulmonary Fibrosis (IPF) is a severe fibrotic lung disease characterized by excessive collagen deposition and progressive decline in lung function.
Dan J. K. Yombo   +8 more
doaj   +1 more source

Capsaicin suppresses interleukin-31-induced itching partially involved in inhibiting the expression of dorsal root ganglion interleukin-31 receptor A in male mice

open access: yesNeurobiology of Pain, 2022
To elucidate the mechanisms underlying the antipruritic effect of capsaicin, we investigated how topical application of capsaicin (0.01, 0.1 and 1.0% w/v) affects spontaneous scratching in NC/Nga mice, inerleukin-31 (IL-31) induced in BALB/c mice, and IL-
Iwao Arai   +4 more
doaj   +1 more source

Interleukin-31 in serum and cerebrospinal fluid of dogs with syringomyelia

open access: yesBMC Veterinary Research, 2023
Background Syringomyelia is a spinal cord cavity containing cerebrospinal fluid (CSF)-like fluid. If syringomyelia asymmetrically involves the dorsal horn grey matter of the spinal cord, affected dogs show increased signs of dysesthesia and neuropathic ...
Laura Lemke   +6 more
doaj   +1 more source

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a studyResearch in context

open access: yesEClinicalMedicine, 2023
Summary: Background: Prurigo nodularis is a chronic skin disease characterised by intensely pruritic, hyperkeratotic nodules. Vixarelimab, a human monoclonal antibody, binds to the beta subunit of the oncostatin M receptor, inhibiting signalling of both
Howard Sofen   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy